A phase I clinical trial of navitoclax, a targeted high-affinity Bcl-2 family inhibitor, in combination with gemcitabine in patients with solid tumors (Q33415855)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I clinical trial of navitoclax, a targeted high-affinity Bcl-2 family inhibitor, in combination with gemcitabine in patients with solid tumors |
scientific article |
Statements
1 reference
A phase I clinical trial of navitoclax, a targeted high-affinity Bcl-2 family inhibitor, in combination with gemcitabine in patients with solid tumors (English)
1 reference
James M Cleary
1 reference
Caio Max S Rocha Lima
1 reference
Herbert I Hurwitz
1 reference
Alberto J Montero
1 reference
Catherine Franklin
1 reference
Jianning Yang
1 reference
Alison Graham
1 reference
Todd Busman
1 reference
Mack Mabry
1 reference
Kyle Holen
1 reference
Geoffrey I Shapiro
1 reference
Hope Uronis
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference